- Home
- FIVN vs XENE Comparison
FIVN vs XENE Comparison
Compare FIVN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- XENE
- Stock Information
- Founded
- FIVN 2001
- XENE 1996
- Country
- FIVN United States
- XENE Canada
- Employees
- FIVN N/A
- XENE N/A
- Industry
- FIVN EDP Services
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- FIVN Technology
- XENE Health Care
- Exchange
- FIVN Nasdaq
- XENE Nasdaq
- Market Cap
- FIVN 2.1B
- XENE 2.4B
- IPO Year
- FIVN 2014
- XENE 2014
- Fundamental
- Price
- FIVN $28.84
- XENE $30.30
- Analyst Decision
- FIVN Buy
- XENE Strong Buy
- Analyst Count
- FIVN 21
- XENE 11
- Target Price
- FIVN $42.90
- XENE $54.82
- AVG Volume (30 Days)
- FIVN 2.4M
- XENE 1.4M
- Earning Date
- FIVN 07-31-2025
- XENE 08-07-2025
- Dividend Yield
- FIVN N/A
- XENE N/A
- EPS Growth
- FIVN N/A
- XENE N/A
- EPS
- FIVN N/A
- XENE N/A
- Revenue
- FIVN $1,074,633,000.00
- XENE $7,500,000.00
- Revenue This Year
- FIVN $11.81
- XENE N/A
- Revenue Next Year
- FIVN $9.79
- XENE $253.71
- P/E Ratio
- FIVN N/A
- XENE N/A
- Revenue Growth
- FIVN 14.44
- XENE N/A
- 52 Week Low
- FIVN $21.04
- XENE $26.74
- 52 Week High
- FIVN $49.90
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- FIVN 58.95
- XENE 39.19
- Support Level
- FIVN $25.01
- XENE $30.84
- Resistance Level
- FIVN $29.24
- XENE $32.72
- Average True Range (ATR)
- FIVN 1.16
- XENE 1.07
- MACD
- FIVN 0.23
- XENE -0.19
- Stochastic Oscillator
- FIVN 81.49
- XENE 1.98
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.